142 related articles for article (PubMed ID: 20074160)
1. Prevalence of erosive esophagitis among Japanese patients taking low-dose aspirin.
Yamamoto T; Mishina Y; Ebato T; Isono A; Abe K; Hattori K; Ishii T; Kuyama Y
J Gastroenterol Hepatol; 2010 Apr; 25(4):792-4. PubMed ID: 20074160
[TBL] [Abstract][Full Text] [Related]
2. Low-dose aspirin-induced gastroduodenal mucosal injury in Japanese patients with arteriosclerotic disease.
Tamura I; Fujita T; Tsumura H; Morita Y; Yoshida M; Toyonaga T; Hirano S; Inokuchi H; Kutsumi H; Azuma T
Intern Med; 2010; 49(23):2537-45. PubMed ID: 21139290
[TBL] [Abstract][Full Text] [Related]
3. [Gastroduodenal mucosal injuries by aspirine. Management of the risks].
Martínez M JD; Molano V JC; Henao R SC
Rev Gastroenterol Peru; 2016; 36(2):129-34. PubMed ID: 27409089
[TBL] [Abstract][Full Text] [Related]
4. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
Uemura N; Sugano K; Hiraishi H; Shimada K; Goto S; Uchiyama S; Okada Y; Origasa H; Ikeda Y;
J Gastroenterol; 2014 May; 49(5):814-24. PubMed ID: 23754512
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
Iwamoto J; Saito Y; Honda A; Matsuzaki Y
World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic evidence of mucosal injury in patients taking ticlopidine compared with patients taking aspirin/nonsteroidal antiinflammatory drugs and controls.
Sheikh RA; Romano PS; Prindiville TP; Yasmeen S; Trudeau W
J Clin Gastroenterol; 2002; 34(5):529-32. PubMed ID: 11960063
[TBL] [Abstract][Full Text] [Related]
7. Incidence of and risk factors for upper gastrointestinal complications in patients taking low-dose aspirin in Japan.
Fujisawa N; Inamori M; Endo H; Uchiyama T; Hosono K; Akiyama T; Tomimoto A; Koyama S; Sawabe A; Tanida E; Yanagisawa S; Hata Y; Okada K; Atsukawa K; Watanabe S; Kawamura H; Higurashi T; Nagase H; Akimoto K; Matsuhashi N; Nakajima A
Hepatogastroenterology; 2011; 58(105):229-34. PubMed ID: 21510320
[TBL] [Abstract][Full Text] [Related]
8. Small-bowel mucosal injuries in low-dose aspirin users with obscure gastrointestinal bleeding.
Iwamoto J; Mizokami Y; Saito Y; Shimokobe K; Honda A; Ikegami T; Matsuzaki Y
World J Gastroenterol; 2014 Sep; 20(36):13133-8. PubMed ID: 25278707
[TBL] [Abstract][Full Text] [Related]
9. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
10. Significant role of aspirin use in patients with esophagitis.
Lanas A; Hirschowitz BI
J Clin Gastroenterol; 1991 Dec; 13(6):622-7. PubMed ID: 1761835
[TBL] [Abstract][Full Text] [Related]
11. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].
Ehrmann J; Procházka V; Konecný M; Spacek M; Urbánek K
Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422
[No Abstract] [Full Text] [Related]
12. The prevalence of gastroduodenal mucosal injuries in aspirin users.
Thongbai T
J Med Assoc Thai; 2013 Nov; 96(11):1423-7. PubMed ID: 24428091
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
Yeomans N; Lanas A; Labenz J; van Zanten SV; van Rensburg C; Rácz I; Tchernev K; Karamanolis D; Roda E; Hawkey C; Nauclér E; Svedberg LE
Am J Gastroenterol; 2008 Oct; 103(10):2465-73. PubMed ID: 18637091
[TBL] [Abstract][Full Text] [Related]
14. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
Goldstein JL; Scheiman JM; Fort JG; Whellan DJ
J Cardiovasc Pharmacol; 2016 Aug; 68(2):121-6. PubMed ID: 27002280
[TBL] [Abstract][Full Text] [Related]
16. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
Nema H; Kato M
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
[TBL] [Abstract][Full Text] [Related]
17. Endoscopy in asymptomatic minidose aspirin consumers.
Niv Y; Battler A; Abuksis G; Gal E; Sapoznikov B; Vilkin A
Dig Dis Sci; 2005 Jan; 50(1):78-80. PubMed ID: 15712641
[TBL] [Abstract][Full Text] [Related]
18. [Digestive complications of aspirin].
Hochain P; Capet C; Colin R
Rev Med Interne; 2000 Mar; 21 Suppl 1():50s-59s. PubMed ID: 10763205
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of gastroduodenal ulcer in Japanese patients taking low-dose aspirin.
Iwamoto J; Mizokami Y; Shimokobe K; Ito M; Hirayama T; Saito Y; Ikegami T; Honda A; Matsuzaki Y
Dig Dis Sci; 2010 Aug; 55(8):2270-4. PubMed ID: 19936921
[TBL] [Abstract][Full Text] [Related]
20. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration].
Wildgrube HJ; Kierschke G; Nowak H; Weigmann I; Terhaag B
Arzneimittelforschung; 2002; 52(4):264-72. PubMed ID: 12040969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
